Market Research Logo

The Global Market for Adjunctive Therapies in Cancer, 2nd Edition

Adjunctive therapies are not only vital to the success of cancer treatments, enhancing compliance and outcomes, but they are also a dynamic area of research and development in a variety of disciplines from drug delivery to biologics. It also happens to be the largest portion of the overall cancer therapeutics market.

This report provides the reader with a comprehensive analysis of the worldwide market for therapeutics to treat and manage symptoms in cancer patients. Market information, including market size and growth, is provided for 2003 to 2010 on various product subcategories included in the major segments:

  • antinauseants and antiemetics
  • pain management
  • blood modifiers
  • infection control
  • other therapies.

In addition, competitive market share and a four-region geographic breakdown are provided for the base year 2005. The study also covers issues and trends affecting the market, research and development pipelines, demographics, cancer statistics, the epidemiology of side effects, and more.


  • Executive Summary
    • INTRODUCTION
      • Table Cancer Incidence and Deaths as a Percentage to Population by Selected Country/Region 2005
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table The World Market for Adjunctive Therapies in Cancer Revenues and Growth Rate 2003-2010
    • ISSUES AND TRENDS AFFECTING THE GLOBAL MARKET
    • LEADING COMPETITORS
  • Introduction
    • OVERVIEW OF CANCER
      • Biology of Cancer
        • Table List of Cancers
      • Treatments and Symptoms
        • Table Side Effects Associated with Chemotherapy
        • Table Side Effects Associated with Radiation Therapy
    • ADJUNCTIVE THERAPY OVERVIEW: PRODUCT TYPES AND ADMINISTRATION
      • Oral
      • Rectal
      • Transdermal and Nasal
      • Intravenous or Subcutaneous
    • DEMOGRAPHICS,PREVALENCE,INCIDENCE,MORTALITY
      • Table Population by Country 2003-2010
      • Table Cancer Incidence and Mortality by Major Market Country 2005
      • Table Cancer Incidence and Deaths as a Percentage to Population by Selected Major Market Country/Region
  • Issues and Trends
    • OVERVIEW
    • GEOGRAPHICAL TRENDS
      • United States
      • European Union
      • Japan
    • REGULATORY AUTHORITIES
      • Clinical Trials
      • New Indications
    • LIFESTYLE AND SOCIAL ISSUES
    • BARRIERS TO ADJUNCTIVE THERAPIES
    • DRUG DELIVERY ADVANCEMENTS
    • PAIN MANAGEMENT MEASURES
    • OXYCONTIN ISSUES
    • CANCER-RELATED FATIGUE ISSUES
    • INDIVIDUALIZED CHEMOTHERAPY
    • CHEMOTHERAPY AND MEMORY LOSS
  • Antinauseants and Antiemetics
    • OVERVIEW
      • Table Chemotherapy Agents and Level of Emetic Potential
      • Table Time Course of Selected Products in Nausea and Vomiting
    • PRODUCTS
      • Serotonin Receptor Antagonists
      • Phenothiazines
      • Metoclopramide and Other Drugs
    • DRUG DELIVERY METHODS FOR ANTINAUSEANTS AND ANTIEMETICS
      • Table Selected Prescription Antinauseants/Antiemetics by Available Delivery Method
    • RESEARCH AND DEVELOPMENT
      • Table Antinauseants and Antiemetics in Development for Treatment of Cancer related Nausea and Vomiting
    • MARKET OVERVIEW
      • Table The Adjunctive Therapy Antinauseant and Antiemetic Market 2003-2010
      • Table The Adjunctive Therapy Antinauseant and Antiemetic Market Estimated Products Sales by Geographic Region, 2005
    • COMPETITIVE ANALYSIS
      • Table Leading Suppliers' Revenues and Share of the Antinauseants and Antiemetics Segment of the Cancer Adjunct Market 2005
  • Pain Management
    • OVERVIEW
      • Pain Pathways
      • Primary Cancer Pain
        • Table The World Health Organization Three-Step Analgesic Ladder
      • Breakthrough Cancer Pain
    • CANCER PAIN DELIVERY METHODS
      • Oral
      • Oral Transmucosal
      • Parenteral
      • Transdermal
      • Rectal
      • Intranasal
    • DESCRIPTION OF PRODUCTS
      • Primary Cancer Pain Medications
        • Table Selected Prescription Non-Narcotic Analgesics by Available Delivery Method
        • Table Selected Over-the-Counter Non-Narcotic Analgesics by Available Delivery Method
        • Table Selected Prescription Narcotic Analgesics by Available Delivery Method
      • Breakthrough Cancer Pain Medications
        • Table Selected Prescription Antidepressants Used for Cancer Pain by Available Delivery Method
        • Table Selected Prescription Anticonvulsants Used for Cancer Pain by Available Delivery Method
        • Table Selected Prescription Corticosteroids Used for Cancer Pain by Available Delivery Method
        • Table Selected Prescription Bisphosphonates and Calcitonins Used for Cancer Pain by Available Delivery Method
        • Table Selected Prescription Radiopharmacuticals Used for Cancer Pain by Available Delivery Method
    • RESEARCH AND DEVELOPMENT
      • Table Pain Management Products in Development for Treatment of Cancer Related Pain
    • MARKET OVERVIEW
      • Table The Adjunctive Therapy Pain Management Market 2003-2010
      • Table The Adjunctive Therapy Pain Management Market Estimated Sales by Geographic Region, 2005
    • COMPETITIVE ANALYSIS
      • Table Leading Suppliers' Shares of the Global Market for Adjunctive Therapies in Cancer: Pain Management 2005
  • Biological Response Modifiers
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Hematopoietic Growth Factors
      • Cytomodulatory Agents
        • Table Selected Biological Response Modifiers and Available Delivery Method
    • RESEARCH AND DEVELOPMENT
      • Table Biological Response Modifiers in Development for Treatment of Cancer related Infection
    • MARKET OVERVIEW
      • Table The Adjunctive Therapy Biological Response Modifier Market 2003-2010
      • Table The Adjunctive Therapy Biological Response Modifier Market Estimated Products Sales by Geographic Region, 2005
    • COMPETITIVE ANALYSIS
      • Table Leading Suppliers' Revenues and Share of Biological Response Modifiers Segment 2005
  • Infection Control
    • OVERVIEW
      • Table Common Infection Sites and Organisms
    • DESCRIPTION OF PRODUCTS
      • Anti-Bacterials and Antivirals
        • Table Selected Prescription Antibacterial and Antiviral Agents and Available Delivery Method
      • Antifungals
        • Table Selected Prescription Antifungals and Available Delivery Method
    • RESEARCH AND DEVELOPMENT
      • Table Anti-Infective Agents and Antifungals in Development for Treatment of Cancer related Infection
    • MARKET OVERVIEW
      • Table The Adjunctive Infection Control Market 2003-2010
      • Table The Adjunctive Therapy Infection Control Market Estimated Sales by Geographic Region, 2005
    • COMPETITIVE ANALYSIS
      • Table Leading Suppliers' Revenues and Shares of the Infection Control Segment 2005
  • Other Adjunctive Therapies
    • OVERVIEW
      • Fatigue
      • Anorexia/Cachexia/Weight Loss
      • Diarrhea
      • Constipation
      • Alopecia (Hair Loss)
        • Table Selected Chemotherapy Agents and Level of Hair Loss Potential
      • Radiation-Induced Dermatitis
      • Other
    • DESCRIPTION OF PRODUCTS
      • Fatigue
        • Table Selected Prescription and Non-prescription Products to Minimize Symptoms of Fatigue in Cancer Patients and Their Available Delivery Method
      • Anorexia/Cachexia/Weight Loss
        • Table Selected Prescription Products for the Treatment of Anorexia/Cachexia in Cancer Patients and Available Delivery Method
      • Diarrhea
        • Table Selected Prescription and Non-prescription Products for the Treatment of Diarrhea in Cancer Patients and Available Delivery Method
      • Constipation
        • Table Selected Prescription and Non-prescription Products for the Treatment of Constipation in Cancer Patients and Available Delivery Method
      • Hair Loss
      • Radiation-Induced Dermatitis
        • Table Selected Prescription and Non-prescription Products for the Treatment of Radiation-induced Dermatitis
    • RESEARCH AND DEVELOPMENT
      • Table Other Adjunctive Therapies in Development for Treatment of Cancer
    • MARKET OVERVIEW
      • Table The Adjunctive Therapy Other Products Market 2003-2010
      • Table The Adjunctive Therapy Other Products Market Estimated Products Sales by Geographic Region, 2005
    • COMPETITIVE ANALYSIS
  • Market Summary
    • OVERVIEW
    • MARKET SIZE
      • Table The World Market for Adjunctive Therapies in Cancer 2003-2010
      • Table The Global Market for Adjunctive Therapies in Cancer by Type, 2003-2010
    • COMPETITIVE ANALYSIS
      • Table Leading Suppliers, Products, and Segments of Participation 2005
    • MARKET ANALYSIS
  • Company Profiles
    • INTRODUCTION
    • COMPETITIVE SUMMARY
    • ABBOTT LABORATORIES
    • AMGEN,INC.
    • BAYER CORPORATION
    • CEPHALON ,INC
    • CHUGAI PHARMACEUTICAL COMPANY LTD.
    • ELI LILLY &COMPANY
    • GLAXOSMITHKLINE PLC
    • JOHNSON &JOHNSON
    • NOVARTIS PHARMACEUTICALS CORPORATION
    • PFIZER,INC.
    • ROCHE GROUP
    • SANOFI -AVENTIS
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report